416 related articles for article (PubMed ID: 25828520)
1. Dendritic-tumor fusion cells in cancer immunotherapy.
Takakura K; Kajihara M; Ito Z; Ohkusa T; Gong J; Koido S
Discov Med; 2015 Mar; 19(104):169-74. PubMed ID: 25828520
[TBL] [Abstract][Full Text] [Related]
2. Dendritic-Tumor Fusion Cell-Based Cancer Vaccines.
Koido S
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240347
[TBL] [Abstract][Full Text] [Related]
3. Cell fusion between dendritic cells and whole tumor cells.
Koido S; Gong J
Methods Mol Biol; 2015; 1313():185-91. PubMed ID: 25947665
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
[TBL] [Abstract][Full Text] [Related]
6. Clinically feasible approaches to potentiating cancer cell-based immunotherapies.
Seledtsov VI; Goncharov AG; Seledtsova GV
Hum Vaccin Immunother; 2015; 11(4):851-69. PubMed ID: 25933181
[TBL] [Abstract][Full Text] [Related]
7. The impact of dendritic cell-tumor fusion cells on cancer vaccines - past progress and future strategies.
Kajihara M; Takakura K; Ohkusa T; Koido S
Immunotherapy; 2015; 7(10):1111-22. PubMed ID: 26507578
[TBL] [Abstract][Full Text] [Related]
8. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
[TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy by fusions of dendritic cells and tumor cells.
Koido S; Hara E; Homma S; Ohkusa T; Gong J; Tajiri H
Immunotherapy; 2009 Jan; 1(1):49-62. PubMed ID: 20635973
[TBL] [Abstract][Full Text] [Related]
10. Dendritic/tumor fusion cell-based vaccination against cancer.
Koido S; Hara E; Homma S; Fujise K; Gong J; Tajiri H
Arch Immunol Ther Exp (Warsz); 2007; 55(5):281-7. PubMed ID: 18219758
[TBL] [Abstract][Full Text] [Related]
11. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation.
Bhargava A; Mishra D; Banerjee S; Mishra PK
Immunotherapy; 2012 Jul; 4(7):703-18. PubMed ID: 22853757
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy.
Shu S; Zheng R; Lee WT; Cohen PA
Crit Rev Immunol; 2007; 27(5):463-83. PubMed ID: 18197808
[TBL] [Abstract][Full Text] [Related]
14. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q
Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.
Kim GY; Chae HJ; Kim KH; Yoon MS; Lee KS; Lee CM; Moon DO; Lee JS; Jeong YI; Choi YH; Park YM
Biosci Biotechnol Biochem; 2007 Jan; 71(1):215-21. PubMed ID: 17213658
[TBL] [Abstract][Full Text] [Related]
16. mRNA-based dendritic cell vaccines.
Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
[TBL] [Abstract][Full Text] [Related]
17. Harnessing dendritic cells in cancer.
Apetoh L; Locher C; Ghiringhelli F; Kroemer G; Zitvogel L
Semin Immunol; 2011 Feb; 23(1):42-9. PubMed ID: 21295491
[TBL] [Abstract][Full Text] [Related]
18. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
